For instance, Islet-1, a factor that interferes in epigenome programing, was found to be stain-positive in 78% of pancreatic NETs and 100% in phechromocytomas/ganglioneuromas, while its expression was negative in parathyroid tumors [184]. This evidence concerns the gene ISL1 and pancreatic neuroendocrine tumor.